ライフサイエンスコーパス: conflict of interest

1 licts of interest and 61% for more intrinsic conflicts of interest).

2 ears [IQR 1.7-6.3]; two [25%] with potential conflicts of interest).

3 ommon, a practice that has the potential for conflict of interest.

4 practice, especially when there is potential conflict of interest.

5 for which there could be any perception of a conflict of interest.

6 ing concerns about intellectual property and conflict of interest.

7 nteraction between two organisms that have a conflict of interest.

8 with studies with other sources of potential conflict of interest.

9 of 29 (17%) among those without a financial conflict of interest.

10 ir guidelines manage both real and perceived conflict of interests.

11 uniclonal, minimizing within-cluster genetic conflicts of interest.

12 aluating therapies and identifying potential conflicts of interest.

13 octoring family members because of potential conflicts of interest.

14 formation about authors' potential financial conflicts of interest.

15 ns involved in running a trial had intrinsic conflicts of interest.

16 have the potential of creating institutional conflicts of interest.

17 licts of interest as compared with financial conflicts of interest.

18 anied by increasing concerns about financial conflicts of interest.

19 ucted on investigator training and potential conflicts of interest.

20 t company, both of which could be considered conflicts of interest.

21 Some view these payments as conflicts of interest.

22 closure, review, and management of financial conflicts of interest.

23 socio-cognitive skills for dealing with such conflicts of interest.

24 encies in order to analyze their policies on conflicts of interest.

25 n, clear, specific, and credible policies on conflicts of interest.

26 tutions--reported that they had no policy on conflicts of interest.

27 replicators, which generates selfishness and conflicts of interest.

28 at they had policies requiring disclosure of conflicts of interest.

29 n improve the integrity of science or manage conflicts of interest.

30 commercial relationships and other potential conflicts of interest.

31 clinical decision and are not influenced by conflicts of interest.

32 sparency, and identify potential sources for conflicts of interest.

33 55) of podcasts because of nondisclosure of conflicts of interest.

34 ur of these studies showed relevant industry conflicts of interest.

35 ls were judged to have notable concern about conflicts of interest.

36 , and insufficiently stringent management of conflicts of interest.

37 , which are considered significant financial conflicts of interest.

38 ted funding sources, and 12 (37.5%) reported conflicts of interest.

39 hose cooperation is obviated by evolutionary conflicts of interest.

40 ials, and trials not found to have potential conflicts of interest.

41 approaches to research review, and minimize conflicts of interest.

42 eing mindful of the importance of minimizing conflicts of interest.

43 tial bias-is a popular solution for managing conflicts of interest.

44 d the documentation of funding and potential conflicts of interest.

45 reviews and reviews whose authors disclosed conflicts of interest.

46 es did not mention anything about funding or conflicts of interest.

47 cy, monitoring of actions, and management of conflicts of interest.

48 ves and provided disclosure of any potential conflicts of interest.

49 gn, and the involvement of stakeholders with conflicts of interest.

50 he primary studies than those with financial conflicts of interest.

51 these drugs than reviewers without financial conflicts of interest.

52 Only half the CPG panels addressed conflicts of interest.

53 phase clinical trials perceive investigator conflicts of interests.

54 WHO credibility, particularly with regard to conflicts of interest; (2) views were mixed on whether W

55 mong assessments associated with a financial conflict of interest, 7 of 8 (88%) were classified as fa

56 Conflicts of interest about where to go and what to do a

57 scussed by an expert committee, screened for conflicts of interest, according to the Grading of Recom

58 authorization, disclosure or prohibition of conflicts of interest, additional safeguards for sensiti

59 ther physicians and scientists who have such conflicts of interest adequately disclose such relations

60 he greatest transparency regarding potential conflicts of interest, all members of the Joint Task For

61 he greatest transparency regarding potential conflicts of interest, all members of the JTFPP and the

62 ing transparency and management of financial conflicts of interest among committees that develop guid

63 Wide variation in management of conflicts of interest among institutions may cause unnec

64 tical Manual of Mental Disorders to prohibit conflicts of interest among its panel and task force mem

65 Conflicts of interest among panel members of DSM-5-TR we

66 heir attitudes regarding potential financial conflicts of interest among researchers and medical cent

67 rocal parasitisms, which can be disrupted by conflicts of interest among the partners.

68 of D. discoideum is partly competitive, with conflicts of interests among cells.

69 to significantly influence public trust: 1) conflict of interest and objectivity; 2) public benefit;

70 istered with clinicaltrials.gov (NCT02365194)Conflict of Interest and Source of Funding: This work wa

71 Policies for conflict of interests and publicly available data are la

72 tients on research trials (52% for financial conflicts of interest and 61% for more intrinsic conflic

73 versight system to protect against financial conflicts of interest and about researchers' financial i

74 mplemented consistently in order to mitigate conflicts of interest and address such interactions' pot

75 Five studies had potential conflicts of interest and design limitations that affect

76 act with the food industry can be subject to conflicts of interest and reputational risks, but new gu

77 ey that addressed multiple issues related to conflicts of interest and research participation.

78 [IQR 13.0-37.5]); three [60%] with potential conflicts of interest), and eight prospective cohort stu

79 sed adequacy of blinding, 18 (53%) disclosed conflicts of interest, and 19 (56%) received funding fro

80 tential model biases, 52% failed to disclose conflicts of interest, and 74% failed to describe method

81 erventions are beneficial, address potential conflicts of interest, and be available to persons who c

82 will be more prone to anger, prevail more in conflicts of interest, and consider themselves entitled

83 Sloppiness, oversights, conflicts of interest, and failure to share were less se

84 in formulating guidelines, failure to state conflicts of interest, and lack of consultation with fam

85 Development and Evaluation methods, managing conflicts of interest, and making values and preferences

86 ties of clinicians harbor concerns regarding conflicts of interest, and many are uncertain of the pra

87 ving access to and quality of care, managing conflicts of interest, and professional self-regulation.

88 articles should disclose potential financial conflicts of interest, and readers of review articles sh

89 ionships, however, often produce significant conflicts of interest, and recent attention has focused

90 assessment of depression, severity, reported conflicts of interest, and study quality.

91 ollowed a written protocol, had no disclosed conflicts of interest, and were blinded to all study hyp

92 management of potential impacts of financial conflicts of interest; and 3) transparency in research m

93 Content producers need to disclose their conflicts of interest appropriately to ensure credibilit

94 Conflicts of interest are known to create problems for t

95 tiple eggs are laid into a host, inter-clone conflicts of interest arise.

96 Conflicts of interest arising from these ties can influe

97 more, concerned about traditional intrinsic conflicts of interest as compared with financial conflic

98 re professionals and scientists also present conflicts of interest, as does the dual purpose for the

99 miRNAs to represent both a means to resolve conflicts of interest, as well as instigate them.

100 l discuss and resolve all relevant potential conflicts of interest associated with this selection.

101 l discuss and resolve all relevant potential conflicts of interest associated with this selection.

102 Disclosures of conflicts of interest at drug advisory committee meeting

103 Policies governing conflicts of interest at leading medical schools in the

104 e is substantial variation among policies on conflicts of interest at medical schools and other resea

105 We analyzed policies governing conflicts of interest at the 10 medical schools in the U

106 Removing studies with potential conflicts of interest attenuated the estimates.

107 For humans, however, reproductive conflicts of interest became a spur for increasing intel

108 tead viewed as an outcome of an intragenomic conflict of interest between an individual's genes.

109 ups experience time pressure and significant conflict of interest between members (due to various bet

110 s provides a mechanistic explanation for the conflict of interest between the intermediate consumer a

111 umes that its high prevalence is driven by a conflict of interests between parents and daughters, wit

112 a that natural selection drives intragenomic conflicts of interest between genes originating from dif

113 on about parent of origin plays in mediating conflicts of interest between genes residing in the same

114 e language could evolve because reproductive conflicts of interest between individuals were reduced.

115 e, the financial relationship with potential conflicts of interest between newly independent physicia

116 Conflicts of interest between physicians' commitment to

117 g games that range from interactions without conflicts of interest between the players to interaction

118 cations for sexual selection, speciation and conflicts of interest between the sexes, and yet they ar

119 Conflicts of interests between males and females over re

120 industry and academia, other issues, such as conflicts of interest (both real and perceived), continu

121 Both species managed to overcome this conflict of interest but used different strategies to do

122 most exclusively on disclosures of financial conflicts of interest but little is known about how disc

123 Responses to these conflicts of interest by medical institutions, journals,

124 Conflicts of interest can arise from other financial tie

125 Although both financial and intrinsic conflicts of interest can exist throughout the drug deve

126 inated duets when responding to rival pairs, conflicts of interest caused duet coordination to break

127 ut each public speaker including presence of conflict of interest (COI) and whether their testimony r

128 t adverse outcomes related to poorly managed conflict of interest (COI) in research, education, and c

129 Financial conflicts of interest (COI) have the potential to advers

130 itors statement on sources of funding and/or conflicts of interest (COI).

131 earch has resulted in increased reporting of conflicts of interest (COI).

132 icate remarkable improvements in some (e.g., conflict of interest [COI] disclosures and funding discl

133 The landscape of managing potential conflicts of interest (COIs) has evolved substantially a

134 Conflicts of interest (COIs) have been defined by the Am

135 Conflicts of interest (COIs) may influence medical liter

136 closure of interests (DOI) and management of conflicts of interest (COIs).

137 Editorial board members may be biased due to conflicts of interest (COIs).

138 Potential bias and undeclared conflicts of interests (COIs) among guideline authors ca

139 itutional review board and the institutional conflict of interest committee.

140 institutional review board and institutional conflict of interest committee.

141 t guidance requiring more detailed financial conflict of interest disclosure at advisory committee me

142 orkgroups will complete a standard potential conflict of interest disclosure form, which will be avai

143 orkgroups will complete a standard potential conflict of interest disclosure form, which will be avai

144 The actual impact of conflict of interest disclosure to research subjects nee

145 and design, but there was a lack of explicit conflict of interest disclosure.

146 In this study of self-reported conflict-of-interest disclosure by physicians at a large

147 aring in 498 (9%), registration in 446 (8%), conflict of interest disclosures in 4209 (79%), and fund

148 tunity to assess the accuracy of physicians' conflict-of-interest disclosures.

149 ips as the companies listed in the article's conflict-of-interest disclosures.

150 nvolvement in p53 research and the potential conflict of interest discussed here demonstrate the need

151 o participate, and to assure the public that conflicts of interest do not compromise either patient s

152 Policies for conflict of interests exist for some financial and a few

153 ders to form their own opinions on whether a conflict of interest exists and what relevance that has

154 Furthermore, conflict of interest exists for Web-based firms because

155 sician-patient relationship, and 52% believe conflict of interest exists.

156 Associations between financial conflicts of interest, favorability assessments, and pre

157 nced by the authors' self-declared financial conflicts of interest (FCOI).

158 Importance: Financial conflicts of interest (FCOIs) among authors of clinical

159 nclear whether global experts with financial conflicts of interest (FCOIs) should be included in, be

160 Here we explore author financial conflicts of interest (FCOIs), sources of guideline fund

161 s been observed among members with financial conflicts of interest (FCOIs).

162 omedical researchers and industry (financial conflicts of interest [FCOIs]) on research prominence.

163 ship, including important issues relating to conflict of interest for both academic and industry part

164 US dialysis facilities presents a financial conflict of interest for nephrologists, who may change t

165 Potential conflicts of interest for clinician-investigators includ

166 However, economic incentives can generate conflicts of interest for investigators, who may be incl

167 panel composition, decision-making process, conflicts of interest, guideline objective, development

168 To meet that need, we propose conflict of interest guidelines for individual biomedica

169 ng Principles has, in this article, proposed conflict-of-interest guidelines regarding industry fundi

170 stry sources and authors who had no relevant conflict of interest had the lowest percentage of positi

171 f the body of evidence relating to financial conflicts of interest has been performed.

172 Concerns about conflicts of interest have driven a wedge between academ

173 policy recommendations addressing financial conflicts of interest have focused on the role of academ

174 to challenges associated with institutional conflicts of interest (ICOI).

175 Most policies on conflict of interest in our sample of major research ins

176 keting activities adequately disclosed their conflict of interest in subsequent journal publications.

177 care delivery can be subject to a potential conflict of interest in supporting both the health inter

178 cal and tobacco companies, which can cause a conflict of interest in the development and marketing of

179 dvisory panel recommended managing perceived conflicts of interest in 26% of the cases, including rec

180 n substantially inform ongoing discussion on conflicts of interest in clinical research.

181 ncies had policies that explicitly addressed conflicts of interest in extramural research, and all bu

182 lection to use bargaining tactics to resolve conflicts of interest in favor of the angry individual.

183 Despite federal regulations on faculty conflicts of interest in federally funded research, acad

184 The mainstay for addressing conflicts of interest in health care is disclosure of pe

185 Given scrutiny over financial conflicts of interest in health care, it is important to

186 s throughout the trial process and minimizes conflicts of interest in individual industry relationshi

187 search on the prevalence and consequences of conflicts of interest in medicine, little attention has

188 Conflicts of interest in research can affect a company's

189 al, and empirical studies of objectivity and conflicts of interest in scientific research, we propose

190 ugh methodological limitations and potential conflicts of interest in some studies raised concern, th

191 This article focuses on the analysis of conflicts of interest in the conduct of clinical trials

192 eration between conspecific individuals with conflicts of interest (including non-kin) can be strateg

193 ore likely to achieve CRC than those without conflict of interest (individual procedure analysis [OR

194 ns of wine value and quality illustrates how conflicts of interest influence decisions about adaptive

195 It is well documented that financial conflicts of interest influence medical research and cli

196 ling to participate in trials after learning conflict of interest information (63%).

197 Patients generally believed that conflict of interest information should be disclosed to

198 e likely to report favorable findings when a conflict of interest is declared.

199 actual compliance with reporting a potential conflict of interest is unable to be determined, the val

200 fe Studies in Transplantation," "Ethical and Conflict of Interest Issues Between Sponsors and Investi

201 es methods to manage, minimize, or eliminate conflict of interest issues, including identification an

202 tion that the main problems are researchers' conflict of interest, lack of institutional review board

203 ur problem areas: sensationalism, biases and conflicts of interest, lack of follow-up, and stories th

204 eans may be problematic because of financial conflicts of interest, lack of patient authorization, in

205 ssess how varying perceptions of typhoid and conflicts of interest led to a nonlinear evolution of co

206 about the Dead Donor Rule, the potential for conflict of interest, making donation happen, and the ca

207 lementing efficient, effective approaches to conflict of interest management.

208 Predetermined conflict-of-interest management strategies were applied,

209 Predetermined conflict-of-interest management strategies were applied,

210 Conflict of interest may arise when 1 physician serves 2

211 A conflict of interest may indeed result, though not in al

212 Institutional financial conflicts of interest may affect research results.

213 Reviewers with financial conflicts of interest may be more likely to present evid

214 Industry funding and financial conflicts of interest may contribute to bias in the synt

215 ients expressed more concern about financial conflicts of interest may have the potential to influenc

216 Financial incentives and conflicts of interest may influence physician decision-m

217 nt, demarcating responsibilities, minimizing conflict of interest, meeting community expectations, an

218 And within group conflicts of interest most prominently between generatio

219 funding source; disclosure and management of conflicts of interest; multidisciplinary input; incorpor

220 tion, and case review; 6) abuse of power and conflicts of interest must be avoided; 7) ethics consult

221 tration number and included statements about conflicts of interest (n = 952; 89.1%) and funding (n =

222 determine the effect of author disclosure of conflict of interest on scientific reporting.

223 ness about the potential impact of financial conflicts of interest on biomedical research, no compreh

224 nfluence of private sector actors with major conflicts of interest on public policy development, and

225 There is substantial concern that financial conflicts of interest on the part of investigators condu

226 The impact of the removal of persons with conflicts of interest on the vote margins was also evalu

227 al review board as well as to a committee on conflicts of interest or a university official.

228 birth more than doubled in studies reporting conflicts of interest (OR, 2.50; 95% CI, 1.70-3.67; 5 st

229 guidelines lack transparency, are tainted by conflicts of interest, or fail to employ rigorous method

230 asked whether dyads of gibbons would solve a conflict of interest over food rewards.

231 ot serve as voting members, and well-defined conflict of interest polices are in place.

232 development of clearer and more transparent conflict of interest policies and procedures to limit an

233 Content of the conflict of interest policies varied widely across insti

234 Conflict of interest policies were strictly followed in

235 The AHA has rigorous conflict-of-interest policies and procedures to minimize

236 Conflict-of-interest policies were strictly followed dur

237 Conflict-of-interest policies were strictly followed in

238 Conflict-of-interest policies were strictly followed in

239 Conflicts of interest policies have become a part of the

240 ASCO Guidelines follow the ASCO Conflict of Interest Policy for Clinical Practice Guidel

241 ASCO's Conflict of Interest Policy Implementation for Clinical

242 ASCO Living Guidelines follow the ASCO Conflict of Interest Policy Implementation for Clinical

243 Society of Clinical Oncology's (ASCO's) new conflict of interest policy reflects a commitment to tra

244 A formal conflict of interest policy was developed at the onset o

245 A formal conflict of interest policy was followed and enforced th

246 A formal conflict of interest policy was followed throughout the

247 adherence to the American Heart Association conflict of interest policy was maintained throughout th

248 cademy of Sciences (NAS) developed its first conflict of interest policy, requiring committee members

249 ine standard operating procedures manual and conflict-of-interest policy were followed throughout.

250 Institute on Medicine as a Profession (IMAP) Conflicts of Interest Policy Database score.

251 Conflicts of interest pose a threat to the integrity of

252 All task force members followed all conflict-of-interest procedures as documented in the Ame

253 g concerns highlighted include standards for conflict of interest, recruitment and remuneration pract

254 Yet accumulating 'conflict of interest' regulations in academic health cen

255 ntaining professional boundaries (minimizing conflict of interest, respecting shared decision-making,

256 dentiality, fiduciary obligations (including conflicts of interest), responsibilities arising from pa

257 porate interference; and implementing robust conflict of interest safeguards in policy making, resear

258 offspring is complicated by an evolutionary conflict of interest ('sexual conflict') between the two

259 far from a purely cooperative exercise, as a conflict of interest ('sexual conflict') exists over the

260 Most patients reported that potential conflicts of interest should be disclosed to patients on

261 Kin selection theory predicts that conflicts of interest should usually be reduced but not

262 In an effort to regulate physician conflicts of interest, some US academic medical centers

263 Furthermore, if only studies including a conflict of interest statement were included (66 of 81),

264 Annually, all members completed conflict of interest statements; no conflicts were ident

265 e that there is an appropriate way to handle conflicts of interest stemming from relationships with i

266 unding agencies do not require disclosure of conflicts of interest, suggests that the current standar

267 s expressed more concern regarding financial conflict of interest than older patients (odds ratio, 6.

268 The article also discusses the potential conflicts of interest that can arise when clinicians sta

269 n, the authors first identified and analyzed conflicts of interest that may affect the activities, le

270 rtial expertise, EACs help address potential conflicts of interest that may arise when researchers an

271 scrutiny in recent years because they create conflicts of interest that pose a risk of biasing the ju

272 types of pressures, misguided thinking, and conflicts of interest that sometimes led their predecess

273 nters would take the lead in eliminating the conflicts of interest that still characterize the relati

274 concerns and confronts the dependencies and conflicts of interest that undermine the public good is

275 ations have become blurred and this produces conflicts of interests that have led to this crisis of t

276 m to test a prevailing idea in the domain of conflict-of-interest: that expertise in a domain insulat

277 year, the funding of the study, the authors' conflict of interest, the threshold of willingness-to-pa

278 speed reviews and none are entirely free of conflicts of interest, the private equity model is parti

279 to which Committee members are screened for conflicts of interest, the workgroups that gather inform

280 While these payments may pose conflicts of interest, their relationship with overall h

281 Because of the potential for conflicts of interest to lead to biased judgments, the 2

282 esearch institutions report the existence of conflicts of interest to the funding agency but allow th

283 Financial conflicts of interest, ubiquitous in cardiovascular medi

284 A consistent method for addressing potential conflict of interest was followed if task force members

285 In 79%, a related conflict of interest was reported.

286 % CI = 0.45, 0.71]), as well as studies with conflict of interest were more likely to achieve CRC tha

287 Until the 1960s, concerns about conflicts of interest were confined to scientists who se

288 Fourth, EC rules on conflicts of interest were followed and the GRADE (Gradi

289 Financial conflicts of interest were identified using the index re

290 Reviewers without financial conflicts of interest were more likely to include statem

291 Studies with conflicts of interest were nearly 4 times more likely to

292 Conflicts of interest were not reported in 16 of the 20

293 There is particular risk for conflict of interest when economic partnerships extend b

294 between cells will frequently be subject to conflicts of interest when they occur between unrelated

295 ed in running a clinical trial had financial conflicts of interest, whereas 65% of patients would be

296 Social primates face conflicts of interest with other partners when their ind

297 Most studies without conflicts of interest with the red meat industry suggest

298 rs as much as senior partners and be wary of conflicts of interest with venture capital entrepreneurs

299 advocacy for kidney health and management of conflicts of interest - with the aim of highlighting the

300 zations, and industry, but free of potential conflicts of interest, would be charged with rigorous ev